Avelas Biosciences Finds $7.4M
socalTECH
SEPTEMBER 10, 2014
San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments. in a Series B funding.
Let's personalize your content